Latest Period
Q4 2025
Security Snapshot
PSYENCE BIOMEDICAL LTD. - Common Shares (PBM) Institutional Ownership
CUSIP: 74449F308
13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025
Institutions Reporting
4
Shares (Excl. Options)
41,956
Price
$0.75
- Type / Class
- Equity / Common Shares
- Symbol
- PBM on Nasdaq
- Shares outstanding
- 1,022,682
- Price per share
- $0.72
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 41,956
- Total reported value
- $31,700
- % of total 13F portfolios
- 0%
- Share change
- -133,398
- Value change
- -$697,282
- Number of holders
- 4
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- PBM - PSYENCE BIOMEDICAL LTD. - Common Shares is tracked under CUSIP 74449F308.
- 4 institutions reported positions in Q4 2025.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 6 to 4 between Q3 2025 and Q4 2025.
- Reported value moved from $763,723 to $31,700.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 74449F308?
CUSIP 74449F308 identifies PBM - PSYENCE BIOMEDICAL LTD. - Common Shares in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74449F308:
Significant Owners of PSYENCE BIOMEDICAL LTD. - Common Shares (PBM) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Kaos Capital Ltd | 4.9% | -70% | $236,098 | 313,876 | 0% | KAOS Capital Ltd. | 08 Jan 2026 | |
| Weiner Jeffrey David | 5.1% | $37,332 | 51,850 | Weiner Jeffrey David | 13 Feb 2026 |
As of 31 Dec 2025, 4 institutional investors reported holding 41,956 shares of PSYENCE BIOMEDICAL LTD. - Common Shares (PBM). This represents 4.1% of the company’s total 1,022,682 outstanding shares.